Effects of antenatal magnesium sulfate use for neuroprotection on cardiorespiratory complications during the early neonatal period in preterm infants
| Autor: | Abdulkadir Turgut, Meryem Hocaoğlu, Nuran Üstün, Fahri Ovali |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
business.industry
Magnesium chemistry.chemical_element Cardiorespiratory fitness Early neonatal period Antenatal magnesium sulfate Neonatal resuscitation Patent ductus arterisus Preterm infants Neuroprotection Pediatrics Neuroprotection Pediatri chemistry Anesthesia Medicine business Neonatal resuscitation |
| Zdroj: | Volume: 5, Issue: 9 843-847 Journal of Surgery and Medicine |
| ISSN: | 2602-2079 |
| DOI: | 10.28982/josam.974461 |
| Popis: | Background/Aim: Antenatal magnesium sulfate (MgSO4) treatment is widely used for fetal neuroprotection in women at risk of preterm delivery. Possible adverse effects of MgSO4 include respiratory depression and delay in closure of ductus arteriosus by antagonism of calcium channels. The aim of this study was to investigate the effects of antenatal MgSO4 exposure on cardiorespiratory complications during the early neonatal period in premature infants.Methods: A retrospective cohort study was performed on 340 preterm infants born between 23 and 32 weeks of gestational age. Patients were divided into two groups according to antenatal MgSO4 exposure: The MgSO4 group (n=186) and the no-MgSO4 group (n=154). Outcomes were acute cardiorespiratory events (intubation at birth, respiratory support, and hypotension in first day of life), and hemodynamically significant patent ductus arteriosus (HsPDA).Results: Mothers in the MgSO4 group were more likely to have preeclampsia and antenatal steroid treatment, while their infants were younger in gestation and weighed less (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|